How to Buy Humacyte Stock

Humacyte Inc

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

Humacyte stock last closed at $1.68, up 8.39% from the previous day, and has decreased 46.15% in one year. It has overperformed other stocks in the Biotechnology industry by 0.32 percentage points. Humacyte stock is currently +46.09% from its 52-week low of $1.15, and -83.15% from its 52-week high of $9.97.

There are currently 155.12M shares of HUMA outstanding. The market cap of HUMA is $260.60M. In the past 24 hours, 3.09M HUMA shares were traded.

How to Buy Humacyte Stock

Not sure how to invest in Humacyte stock? Here's how.

  1. Decide where to buy Humacyte stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Humacyte stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your investment account: Pick your method of payment and add your information.
  4. Research Humacyte stock: The Humacyte ticker symbol is HUMA. Is Humacyte stock a good investment? Should you buy shares of HUMA? How do HUMA's underlying business fundamentals look? Do top analysts think Humacyte is a good buy? Why has HUMA's stock price moved recently? (Hint: Our stock market research website can help you figure out if HUMA is a good stock to buy).
  5. Make your HUMA trade: Decide if you will purchase HUMA shares at the current market price or use a limit order to purchase HUMA shares at a given price.
  6. Get key alerts regarding your investment in HUMA: Create a watchlist to keep tabs on your new investment in Humacyte stock.

Step 1: Decide where to buy Humacyte stock

You need a brokerage account in order to access the NASDAQ market and buy HUMA shares.

A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've chosen the best brokerage, you'll need to fill out some personal details so you can buy HUMA today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to create your new trading account.
  1. Submit your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have created your account on the highest rated app to buy and sell stocks, your next step is to transfer the money for your investment:

Watch this video walkthrough to see the process of transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Humacyte stock

Once you have decided on the best place to buy Humacyte stock, it's important to analyze their stock prior to buying, so you actually understand the risk and opportunity.

Humacyte Metrics

HUMA Price
$1.68
1w %
7.01%
1y %
-46.15%
5y %
N/A
P/E
-1.33x
P/B
-4.95x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$148.70M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$260.60M
Next Earnings
May 8, 2025
Next Dividend
N/A

Humacyte Due Diligence Score

WallStreetZen was designed to help everyday investors perform better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on HUMA's stock page.

How is HUMA stock valued?

Investors use many financial metrics, analyses, models, and charts to gauge HUMA's fair value.

You can access additional valuation research on HUMA's stock here.

HUMA Financial Health Summary

Signs that HUMA is financially healthy:

  • There are more short-term assets than short-term liabilities on the HUMA balance sheet.

Signs that HUMA is not financially healthy:

  • HUMA has $95.15M in cash and short term investments. This is not sufficient to cover its annual cash burn of $99.69M.
  • There are more long-term liabilities than short-term assets on the HUMA balance sheet.
  • HUMA debt to equity ratio of -3.62 is negative.
  • Total HUMA debt is still negative.
  • HUMA has cash burn of 99694000. It does not have sufficient cash and short-term investments to cover this.

Do analysts think it's a good time to buy Humacyte stock

Out of 3 Equities analysts who monitor HUMA, the consensus analyst rating on Humacyte is a Strong Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are forecasting on the Humacyte stock forecast page.

HUMA Momentum

SMA10
1.47
SMA20
1.81
SMA50
2.77
SMA100
3.64
SMA200
4.89
MACD
-0.39
MACD Signal
-0.46
MACD Histogram
0.07
RSI
38.92
Stochastic %K
50.16
Stochastic %D
39.46
StochRSI %K
100
StochRSI %D
94.48

HUMA Earnings

Last year, HUMA revenue was $0.00. During the last 5 year, HUMA's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 44.43%.

Find out more about HUMA's earnings and revenue performance here.

Who is buying/selling HUMA?

In the last 12 months, insiders at HUMA have sold more shares than they have bought.

William John Scheessele, Chief Commercial Officer of HUMA, was the latest HUMA insider to buy. They bought $9,999.22 worth of HUMA stock on Apr 14, 2025.

Dig into more about who owns HUMA stock here.

Can I rely on HUMA as an income stream?

No, Humacyte doesn't provide an income stream by paying out dividends.

HUMA Social Trading Data

One of the reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your HUMA trade

You have two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact price, place a limit order.

Press the Open Trade button and eToro will execute your order.

If you want additional info about buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Get key alerts regarding your investment in HUMA

Now that you own some HUMA shares, you'll want to stay up-to-date on your new investment.

Create a watchlist to track the latest developments regarding your HUMA stock.

HUMA Feed

How to Buy Stock in Humacyte

To reiterate, here are the 6 steps to buy stock in Humacyte:

  1. Decide where to buy Humacyte stock
  2. Open a brokerage account
  3. Deposit funds into your investment account
  4. Research Humacyte stock
  5. Make your HUMA trade
  6. Get key alerts regarding your investment in HUMA

If you require a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep tabs on your investment in Humacyte, click below.

NASDAQ: HUMA
$1.68+0.13 (+8.39%)
Updated Apr 17, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: HUMA
$1.68+0.13 (+8.39%)
Updated Apr 17, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Humacyte share?

As of Apr 17, 2025, it costs $1.68 to buy one share of Humacyte stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.84, you can buy 0.5 shares of HUMA.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Humacyte stock?

According to 3 Wall Street analysts who monitor Humacyte, their consensus recommendation is to buy Humacyte stock.

What is the best way to buy Humacyte stock?

One way to place an order for Humacyte stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.